Title : Targeting immune suppression with PDE5 inhibition in end-stage multiple myeloma.

Pub. Date : 2014 Aug

PMID : 24878583






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Here, we show how the addition of the PDE5 inhibitor, tadalafil, in a patient with end-stage relapsed/refractory multiple myeloma reduced MDSC function and generated a dramatic and durable antimyeloma immune and clinical response. Tadalafil phosphodiesterase 5A Homo sapiens